Review

Apple needs new sources of growth: perhaps the company can boost its profits by integrating AI into its devices. Photo: Apple
Review·
What Is Anthropic Hiding? Google Is "Eating" Itself, and Netflix Has Fallen Into Its Own Trap
Following the release of the earnings report, at least 25 teams of investment analysts lowered their price targets for Alphabet stock. Photo: Unsplash / Alban
Review·
Alphabet Disappointed the Market. Why Its Stock May Still Be Attractive to Investors
Polls show that U.S. President Donald Trump’s Republican Party is unlikely to retain its majority in Congress in the upcoming elections / Photo: The White House
Review·
U.S. Elections: What Will Happen to the AI Sector, Oil, Gold, and the Dollar After November 3?
Goldman Sachs has added CXMT to its updated list of recommendations for Chinese AI companies. To date, the country’s STAR50 technology index has fallen more than 45% from its July peak. Photo: Poetra.RH / Shutterstock.com
Review·
From South Korea to China: The Asian AI Bubble Is Bursting. Should You Buy Stocks?
Review·
Top Stories This Morning: Binance Confirms $6 Billion Hack; Intel and Amazon Trigger Sell-Off
Review·
Anthropic warns of AI blackmail risks. What does this mean for investors?
Review·
CoreWeave: How a Single Equation Helps Identify the Main Risk in the AI Business
Review·
Apple no longer wants to rely solely on the iPhone. Where is it looking for new sources of growth?
Stock Screener
Buy
Sell
Go to section
Small Caps
A group of investors led by billionaire Nelson Peltz’s fund wants to buy burger chain Wendy’s / Photo: Shutterstock.com
Small Caps·
Small caps last week: Battle for Wendy’s, Brazil selloff, Innodata layoffs
Build-A-Bear shares have lost half their value over the last 12 months / Photo: Shutterstock.com
Small Caps·
Burry sees value in Build-A-Bear shares as the business faces more tough quarters
Aspen Neuroscience shares will trade on the Nasdaq under the ticker symbol ASPE / Photo: Unsplash / Vitaly Gariev
Small Caps·
Aspen IPO: Altman-backed, Parkinson’s-focused biotech debuts on the Nasdaq
Bambusa Therapeutics raised $168.9 million in its Nasdaq IPO / Photo: Unsplash / CDC
Small Caps·
Bambusa IPO: Dermatology biotech to debut on the Nasdaq
Ultralife manufactures non-rechargeable and rechargeable batteries and communications equipment / Photo: www.ultralifecorporation.com
Small Caps·
Battery maker Ultralife soars 145% on takeover by rival EnerSys
Go to section
News
The owner of the Icelandic geothermal resort Blue Lagoon is preparing for an IPO / Photo: Palmi Gudmundsson / Shutterstock
News·
The Long-Awaited Anthropic Prospectus: Blue Lagoon Goes Public—Key Details on the IPO by November 1
Fitch’s decision came ahead of fresh protests across France / Photo: Shutterstock
News·
Fitch cuts France’s credit rating outlook ahead of fresh protests
The selloff followed quarterly earnings from major tech companies, with investors most disappointed with Alphabet and Amazon, two heavyweights at the forefront of AI investment / Photo: Shutterstock.com
News·
'Emotions are running really high': Tech stocks have worst day since June
Blackstone now considers a credit rating in the BB range or above more likely for Anthropic, the FT reports / Photo: Yalcin Sonat / Shutterstock.com
News·
FT: Anthropic may receive a junk credit rating after its IPO
Photo: X / NYSE
News·
Nasdaq 100 plunges 4% on Friday, heads for worst month in more than a year and a half
Go to section